The extract from Microphyt, called PhaeOptim, was shown to complement weight management strategies that include diet and exercise by support bone mass, aerobic capacity, resting heart rate, and blood lipid profiles.
A recent study1 found that a microalgae extract from Microphyt (Baillargues, France), called PhaeOptim, may be a valuable complement to a diet and exercise regimen. In the study, 37 overweight but otherwise healthy women were randomized to receive either a placebo or 220 mg per day of the extract, derived from the microalgae strain Phaeodactylum tricornutum, for 12 weeks while following a calorie-restricted diet and exercise routine that involved resistance training and walking.
Results showed that supplementation with the extract did not contribute to additional weight loss or fat loss, but researchers did observe that supplementation did preserved bone mass and density to a greater degree, promoted greater improvements in daily walking steps, resting heart rate, aerobic capacity, blood lipid profiles, adherence to diet goals, as well as functional activity tolerance, pain, and measures of quality of life. For example, women taking the extract experienced a 1.4% increase in bone mineral density while the placebo group saw a 1.9% decrease in bone mineral density. Additionally, women taking the extract saw a 10% increase in relative VO2peak after 6 weeks, a 8.5% reduction in resting heart rate (RHR), and 14.5% higher levels of HDL cholesterol, with a 21% lower ratio of LDL-HDL. According to the researchers, “reduction in RHR is particularly noteworthy given its relationship to reducing myocardial oxygen demand and risk to cardiovascular disease.
“These promising findings demonstrate PhaeOptim supports a holistic approach to weight management interventions by improving major physiological components that could optimize adherence to a healthy lifestyle,” said Jonathan Maury, PhD, clinical research manager of Microphyt, in a press release. “PhaeOptim helped women adhere to weight management interventions goals by improving exercise adaptations creating a more supportive, effective, and possibly comfortable experience.”
“PhaeOptim is a natural, sustainable and clinically proven functional ingredient that can help consumers’ wellness journey by augmenting healthy exercise and dietary choices,” added Maury. “This study demonstrates the efficacy of PhaeOptim in enhancing exercise capacity, and cardiovascular health, as well as preventing bone damage.”
PhaeOptim is standardized to 4.4 mg of fucoxanthin, which is a carotenoid and antioxidant that is naturally present in the microalgae.
Reference
Dickerson, B.; Maury, J.; Jenkins, V.; Nottinghan, K,: Xing, D.; Gonzalez, D.E.; Leonard, M.; Kendra, J. Effects of supplementation with microalgae extract from Phaeodactylum tricornutum (Mi136) to support benefits from a weight management intervention in overweight women. Nutrients. 2024, 16 (7), 990. DOI: 10.3390/nu16070990
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
Standardized valerian extract shows acute sleep benefits after one day, says recent study
December 10th 2024Results showed that after a single dose, people taking the Valerian extract experiences an acute benefit on sleep, namely a significant increase in actual sleep time compared to baseline.